SBUX

Starbucks

$103.13

-1.28%
Nov 20, 2026
Bobby Quantitative Model
Starbucks Corporation operates the world's largest specialty coffee retail network, generating revenue through company-operated stores, licensed-store royalties, packaged coffee and ready-to-drink beverages, and equipment and product sales across its North America (roughly 74% of revenue), International (21%), and Channel Development (5%) segments, with a footprint of nearly 41,000 cafes in more than 80 countries. The company is the category-defining global brand in coffee retail, distinguished by its scale, loyalty program, and vertically integrated sourcing and roasting operations, though it faces intensifying competition from value players and fast-growing drive-thru chains. The current investor narrative centers on the turnaround under CEO Brian Niccol, with recent coverage pointing to comparable sales growth and higher ticket sizes running ahead of schedule, alongside a store-optimization program that includes closing roughly 250 underperforming locations. Debate is split between bulls who see margin recovery and traffic inflection and skeptics focused on a soft international segment, a revenue miss in the fiscal fourth quarter, and a premium multiple that leaves little room for execution error, with M&A speculation around a potential Chipotle acquisition adding a further layer of uncertainty.

People also watch

McDonald's

McDonald's

MCD

Analysis
Yum! Brands

Yum! Brands

YUM

Analysis
Chipotle Mexican Grill

Chipotle Mexican Grill

CMG

Analysis
Restaurant Brands International

Restaurant Brands International

QSR

Analysis
Darden Restaurants

Darden Restaurants

DRI

Analysis

BobbyInvestment Opinion: Should I buy SBUX Today?

Rating: Hold. Starbucks is a high-quality global brand executing a credible turnaround under CEO Brian Niccol — comparable sales growth and higher ticket sizes are running ahead of schedule and the stock has rallied 14.14% in a month versus -2.26% for SPY — but at $106.44 the risk/reward is balanced, with the 30-analyst consensus target of $111.07 implying only +4.3% upside and a recommendation mean of 2.33 that is Hold-leaning despite the headline buy label (15 Buy, 18 Hold, 3 Sell). The core thesis is that margin restoration, not revenue growth, is the entire investment case: revenue is contracting 4.47% year-over-year and the forward PE of 28.6x versus trailing 43.1x already prices in EPS roughly doubling toward the $5.50 consensus estimate.

Supporting evidence is mixed but tilts toward patience rather than aggression. On the positive side, Q4 EPS of $0.59 beat estimates, quarterly EPS has recovered from the $0.26 Q1 trough, Q4 gross margin of 68.0% and net margin of 7.41% rebounded sharply from Q1's 2.96%, and the PEG ratio of 1.21 suggests the growth embedded in the forward multiple is not egregiously priced if recovery materializes. Against that, the payout ratio of 1.12 means the 2.59% dividend yield is not covered by $3.725 billion of trailing free cash flow against $4.44 billion paid out, the current ratio of 0.759 and quick ratio of 0.537 signal tight liquidity, and the 21.8x EV/EBITDA and 3.69x EV/Sales are premium multiples for a 6.66% net margin business with negative revenue growth. The stock's 23.14% one-year gain and position at roughly 83% of its 52-week range mean much of the good news is already discounted.

Three risks could invalidate the thesis: a stalled international segment (the explicit driver of the Q4 revenue miss), margin recovery failing to reach the 14%+ operating levels of fiscal 2023-2024 from the current 9.74%, and M&A speculation around a Chipotle acquisition that could pressure the stock and stretch the balance sheet. This Hold would upgrade to Buy if the stock pulls back toward the $93-$95 support zone (implying roughly 10-12% downside and a more attractive entry) or if two consecutive quarters show positive comparable sales with operating margin above 12%; it would downgrade to Sell on a break below $93 with a further revenue decline or a dividend cut. Valuation verdict: fairly valued to modestly expensive — the stock is not at a historical extreme but already reflects an improving-fundamentals narrative, leaving little margin of safety.

Sign up to view all

SBUX 12-Month Price Forecast

Starbucks is a quality franchise in the middle of a credible but unproven turnaround, and the stock's 14.14% one-month rally versus a -2.26% SPY decline has already captured much of the near-term optimism. The math is the constraint: with the average target at $111.07 (+4.3%) and the stock 4.5% below its 52-week high of $111.50, the risk/reward is balanced, and the wide $82-$141 target spread reflects genuine disagreement about whether margins can return to the 14%+ levels of fiscal 2023-2024. The forward PE of 28.6x is reasonable only if EPS roughly doubles toward $5.50, while the 43.1x trailing PE and 21.8x EV/EBITDA leave little room for execution error given negative revenue growth and a 1.12 payout ratio. I would upgrade to bullish on evidence of two consecutive quarters of positive comparable sales with operating margin above 12%, or on a pullback toward the $93-$95 support zone that restores a margin of safety; I would downgrade to bearish on a break below $93, a further revenue decline, or a dividend cut. Absent either, patience is warranted — the turnaround is real, but so is the price.

Historical Price
Current Price $103.13
Average Target $111.50
High Target $141.00
Low Target $82.00

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Starbucks's 12-month outlook, with a consensus price target around $111.07 and implied upside of +7.7% versus the current price.

Average Target

$111.07

36 analysts

Implied Upside

+7.7%

vs. current price

Analyst Count

36

covering this stock

Price Range

$82 - $141

Analyst target range

Buy
15 (42%)
Hold
18 (50%)
Sell
3 (8%)

Coverage is broad with 30 analysts, but sentiment is mixed: 15 Buy, 18 Hold, and 3 Sell ratings produce a recommendation mean of 2.33 (Hold-leaning) despite the headline "buy" consensus label, and the average target price of $111.07 implies just +4.3% upside from the current $106.44. The consensus is therefore best characterized as cautiously neutral — analysts acknowledge the turnaround but see limited near-term upside after the stock's 14% one-month rally, and recent actions (UBS, Citigroup, Guggenheim, DA Davidson, and Mizuho all reiterating Neutral in late October and early November) confirm a wait-and-see posture rather than conviction buying.

The target range of $82.00 to $141.00 is wide — a 72% spread from low to high — signaling genuine disagreement about the turnaround's durability. The $141 high target implies successful margin recovery toward historical levels plus multiple expansion on restored earnings power, while the $82 low target (essentially the 52-week low) prices in a stalled recovery with continued international weakness and margin compression. With the consensus target only 4.3% above the current price and the stock already near its 52-week high of $111.50, the risk/reward is balanced at best; the wide dispersion and predominantly Neutral ratings suggest the market will need concrete evidence of sustained comparable sales and margin improvement before analysts materially raise targets.

Drowning in data?

Find the real signal!

Bulls vs Bears: SBUX Investment Factors

The bear case currently has slightly stronger evidence on reported fundamentals: revenue is contracting 4.47% year-over-year, the dividend is not covered by earnings at a 1.12 payout ratio, and the consensus target implies only 4.3% upside with a Hold-leaning recommendation mean of 2.33. However, the bull case has momentum and forward-looking support — the 14.14% one-month rally, the 34% PE compression from trailing to forward, and sequential EPS recovery from $0.26 to $0.59 — suggesting the market is already pricing in a recovery that has not yet fully appeared in results. The single most important tension is whether margin restoration toward the 14%+ operating levels of fiscal 2023-2024 materializes before the premium multiple (43.1x trailing PE, 21.8x EV/EBITDA) compresses; if margins recover, the forward PE of 28.6x looks reasonable, but if they stall, the stock has meaningful downside toward the $82 low target. With a beta of 1.012 and the stock 4.5% below its 52-week high, the risk/reward is balanced at best, and concrete evidence of sustained comparable sales and margin improvement is needed before the bull case takes clear precedence.

Bullish

  • Turnaround momentum confirmed by 14% monthly surge: The stock has gained 14.14% over the past month versus a -2.26% decline for SPY, a relative strength spread of +16.40 points. This sharp move off the mid-$90s base in late October to above $109 in early November is characteristic of a trend reversal rather than a temporary bounce, and it has pushed the stock to $106.44, roughly 83% of its 52-week range.
  • Forward EPS implies earnings nearly double: The trailing PE of 43.1x compresses to a forward PE of 28.6x, a 34% gap that implies the market expects EPS to recover from the depressed $0.023 trailing base toward the $5.50 consensus forward estimate. The PEG ratio of 1.21 suggests that if the recovery materializes, the growth embedded in the forward multiple is not egregiously priced.
  • Margin recovery already visible sequentially: Quarterly EPS climbed from $0.26 in Q1 to $0.45 in Q2, $0.91 in Q3, and $0.59 in Q4, while Q4 net income of $677.2 million on a 7.41% net margin rebounded sharply from the $293.3 million and 2.96% margin in Q1. Gross margin also recovered to 68.0% in Q4 from the distorted 20.1% in Q2, supporting the margin-restoration thesis.
  • Brand strength underpins premium economics: A 67.7% gross margin and 2.59% dividend yield reflect pricing power and brand equity that restaurant peers cannot match, even with a thin 6.66% net margin. The 41,000-store global footprint and loyalty program provide a durable competitive moat that supports the premium PS of 2.87x and EV/EBITDA of 21.8x.

Bearish

  • Revenue is contracting, not growing: Fiscal Q4 2026 revenue of $9.141 billion fell 4.47% year-over-year, and the trailing four-quarter total of roughly $37.9 billion reflects sequential declines from $9.908 billion in Q1 to $9.141 billion in Q4. Consensus FY revenue of $48.65 billion implies a return to growth that has yet to appear in reported results.
  • Analyst consensus offers only 4.3% upside: The average target price of $111.07 implies just +4.3% upside from $106.44, and the recommendation mean of 2.33 is Hold-leaning despite the headline buy label, with 18 Hold and 3 Sell ratings against 15 Buys. Recent reiterations of Neutral from UBS, Citigroup, Guggenheim, DA Davidson, and Mizuho confirm a wait-and-see posture after the rally.
  • Dividend not covered by earnings: Free cash flow TTM of $3.725 billion against $4.44 billion of dividends paid over the trailing year produces a payout ratio of 1.12, meaning the dividend is not fully covered by earnings. Quarterly FCF has been erratic — just $91.8 million in Q2 versus $1.351 billion in Q3 — leaving limited cushion if the turnaround stalls.
  • Balance sheet limits financial flexibility: The current ratio of 0.759 and quick ratio of 0.537 indicate tight near-term liquidity, while the negative debt-to-equity of -2.92 and negative book value (P/B of -14.20) stem from an equity deficit driven by buybacks and dividends. This constrains the company's ability to absorb shocks or fund aggressive reinvestment.

SBUX Technical Analysis

Starbucks is in a recovery uptrend that has reclaimed most of its prior drawdown: the stock is up 23.14% over the past year and 26.76% year-to-date, and at $106.44 it sits at roughly 83% of its 52-week range of $81.97 to $111.50, about 4.5% below the high. That positioning signals momentum with moderate overextension risk rather than a value opportunity or a falling knife, particularly given the stock has already recovered from a maximum drawdown of -16.4% within the period. The 1-year relative strength versus SPY of +10.87 points confirms genuine outperformance rather than beta-driven drift, with a beta of 1.012 indicating market-like volatility.

Short-term momentum is decisively positive and diverging constructively from the medium-term trend: the stock has gained 14.14% over the past month versus a -2.26% decline for SPY, a relative strength spread of +16.40 points, while the 3-month change is -1.16% and the 6-month change is -0.35%. This pattern — flat-to-negative medium-term performance followed by a sharp one-month surge — is characteristic of a base breakout or trend reversal rather than a temporary bounce, especially since the move has carried price from the mid-$90s in late October to above $109 in early November. The pullback to $106.44 on the latest session (-0.76%) looks like consolidation within the advance, though the elevated short ratio of 4.62 days-to-cover suggests some positioning friction that could amplify moves in either direction.

Key resistance sits at the 52-week high of $111.50, roughly 4.8% above the current price; a clean breakout would confirm the turnaround thesis and likely trigger momentum and short-covering flows. Support is anchored at the 52-week low of $81.97, about 23% below current levels, with intermediate support in the $93-$95 zone where the stock based in September and October. With a beta of 1.012 the stock moves roughly in line with the market, so position sizing should focus on the wide 52-week range (a 36% spread between low and high) and the elevated short interest rather than on outsized systematic volatility.

Beta

1.01

1.01x market volatility

Max Drawdown

-16.4%

Largest decline past year

52-Week Range

$82-$112

Price range past year

Annual Return

+24.8%

Cumulative gain past year

PeriodSBUX ReturnS&P 500
1m+4.1%-9.7%
3m-3.7%-9.9%
6m+0.0%-7.5%
1y+24.8%+4.7%
ytd+22.8%+1.2%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

SBUX Fundamental Analysis

Revenue is contracting at the top line even as the turnaround narrative builds: fiscal Q4 2026 revenue of $9.141 billion fell 4.47% year-over-year, and the trailing four-quarter total of roughly $37.9 billion reflects sequential declines from $9.908 billion in Q1 to $9.532 billion in Q2, $9.323 billion in Q3, and $9.141 billion in Q4. The segment mix shows beverages at $5.367 billion, other products at $1.942 billion, and food at $1.833 billion, with the beverage core still dominant but overall growth dragged by international weakness flagged in the Q4 report. The revenue trajectory implies the investment case rests on margin and traffic recovery rather than top-line acceleration, and consensus FY revenue of $48.65 billion (range $47.52-$51.67 billion) implies a return to growth that has yet to appear in reported results.

Profitability is positive but thin and volatile: Q4 net income was $677.2 million on a 7.41% net margin, down sharply from $1.045 billion and an 11.21% margin in Q3, while the reported gross margin of 68.0% in Q4 compares with 69.7% in Q3 and a distorted 20.1% in Q2 (reflecting a cost-of-revenue reclassification). Operating income of $991.8 million produced a 10.85% operating margin, and the full-year net margin of 6.66% with an operating margin of 9.74% sits well below the 14%+ operating margins Starbucks earned in fiscal 2023-2024, confirming meaningful margin compression during the turnaround. The sequential EPS path of $0.26, $0.45, $0.91, and $0.59 shows recovery from the Q1 trough but no clean upward trend, and the $0.023 trailing EPS figure underscores how depressed current earnings are relative to the $5.50 consensus forward EPS.

Balance-sheet quality is the weak link: the current ratio of 0.759 and quick ratio of 0.537 indicate tight near-term liquidity, and the negative debt-to-equity of -2.92 (with a negative book value reflected in the -14.20 P/B) stems from an equity deficit driven by buybacks and dividends rather than distress, though it limits financial flexibility. Free cash flow TTM of $3.725 billion against $4.44 billion of dividends paid over the trailing year (payout ratio 1.12) means the dividend is not fully covered by earnings, and quarterly FCF has been erratic — $1.274 billion in Q1, just $91.8 million in Q2, $1.351 billion in Q3, and $1.009 billion in Q4. ROE of -32.9% is an artifact of negative equity, while ROA of 8.59% and interest coverage of 8.2x suggest the underlying business still services debt comfortably, but the combination of a 1.12 payout ratio and heavy capex ($375.8 million in Q4 alone) leaves limited cushion if the turnaround stalls.

Quarterly Revenue

$9.1B

2026-09

Revenue YoY Growth

-4.5%

YoY Comparison

Gross Margin

68.0%

Latest Quarter

Free Cash Flow

$3.7B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Beverage Member
Food Member
Other Products Member

Open an Account, get $2 TSLA now!

Valuation Analysis: Is SBUX Overvalued?

Because Starbucks remains profitable (Q4 net income of $677.2 million), the PE ratio is the appropriate primary metric: the trailing PE of 43.1x compares with a forward PE of 28.6x, a 34% compression that implies the market expects earnings to roughly double from the current depressed $0.023 trailing EPS base toward the $5.50 consensus forward EPS. That gap is the entire valuation story — investors are paying for a recovery that has not yet shown up in reported earnings, and the PEG ratio of 1.21 suggests the growth embedded in the forward multiple is not egregiously priced if the recovery materializes.

Relative to the restaurant sector, Starbucks trades at a clear premium: the PS ratio of 2.87x, EV/Sales of 3.69x, and EV/EBITDA of 21.8x are elevated for a company with a 6.66% net margin and negative 4.47% revenue growth, while the 2.59% dividend yield and 67.7% gross margin reflect brand strength that peers cannot match. The premium is defensible only on normalized margins — at the 14%+ operating margins of fiscal 2023-2024, the EV/EBITDA would look far more reasonable — so the multiple is effectively a bet on margin restoration rather than on current profitability. The negative P/B of -14.20 is not meaningful for comparison given the equity deficit.

Historically, Starbucks' PE has ranged from roughly 20.7x (Q3 2024) to 178x (Q4 2025, on trough earnings), with the current 43.1x trailing PE in the upper-middle of that band but well below the 82.3x seen in Q1 2026 and the 48.2x in Q2 2026, indicating the market has already begun pricing in earnings recovery. The PS ratio of 2.87x is near the low end of its multi-year range of roughly 9.6x-16.7x on the historical series, though methodology differences make that comparison imperfect; on a like-for-like basis the stock is not at a historical valuation extreme, which supports the view that the current price reflects improving fundamentals rather than euphoria.

PE

43.1x

Latest Quarter

vs. Historical

High-End

5-Year PE Range 21x~48x

vs. Industry Avg

27.4x

Industry PE ~27.4x*

EV/EBITDA

21.8x

Enterprise Value Multiple

Investment Risk Disclosure

Financial and operational risks center on a contracting top line and a stretched balance sheet. Revenue fell 4.47% year-over-year in fiscal Q4 2026 to $9.141 billion, with sequential declines across all four quarters, meaning the investment case depends entirely on margin and traffic recovery rather than growth. The payout ratio of 1.12 — $4.44 billion of dividends against $3.725 billion of trailing free cash flow — means the dividend is not fully covered by earnings, and quarterly FCF swung from just $91.8 million in Q2 to $1.351 billion in Q3, leaving little cushion if the turnaround stalls. A current ratio of 0.759 and quick ratio of 0.537 compound the liquidity tightness, while the negative debt-to-equity of -2.92 and negative book value reflect an equity deficit that limits financial flexibility.

Market and competitive risks are dominated by valuation compression and intensifying competition. At a trailing PE of 43.1x, EV/EBITDA of 21.8x, and EV/Sales of 3.69x, Starbucks trades at a clear premium to the restaurant sector despite a 6.66% net margin and negative revenue growth, so any disappointment in the margin recovery could trigger multiple compression. The stock's beta of 1.012 means it moves roughly in line with the market, offering no defensive offset in a broad selloff, and the elevated short ratio of 4.62 days-to-cover suggests positioning friction that could amplify moves in either direction. Competition from value players and fast-growing drive-thru chains such as Dutch Bros — whose recent 20-22% sell-off highlights how quickly premium multiples can deflate in this category — plus M&A speculation around a potential Chipotle acquisition, adds further uncertainty to the narrative.

The worst-case scenario is a stalled turnaround in which international weakness persists, comparable sales growth fades, and margin recovery fails to materialize, forcing analysts to cut targets toward the $82 low end of the range. That level is essentially the 52-week low of $81.97 and represents roughly a 23% decline from the current $106.44, consistent with the stock's -16.4% maximum drawdown within the period but larger given the recent rally. A more moderate adverse outcome would see the stock retest the $93-$95 support zone where it based in September and October, a decline of about 11-13%. In the severe case, an investor could lose approximately 23% from current levels, and the wide 72% spread between the $82 low and $141 high targets underscores how genuinely divided the analyst community is about the durability of the recovery.

FAQ

Ranked by severity, the first risk is execution on margins: operating margin of 9.74% must climb toward the 14%+ historical level to justify the 43.1x trailing and 21.8x EV/EBITDA multiples, and a stall below 10% would invite multiple compression. Second is the top line — revenue fell 4.47% year-over-year in Q4 to $9.141 billion with sequential declines across all four quarters, and continued International weakness (the explicit driver of the Q4 miss) would force analysts toward the $82 low target. Third is financial flexibility: the payout ratio of 1.12 means $4.44 billion of dividends exceed $3.725 billion of trailing free cash flow, quarterly FCF swung from $91.8 million in Q2 to $1.351 billion in Q3, and a current ratio of 0.759 with a quick ratio of 0.537 leaves thin liquidity. Fourth is company-specific event risk — M&A speculation around a Chipotle acquisition could pressure the stock on dilution and integration concerns, while the 4.62 short ratio means positioning friction can amplify moves in either direction.

The 12-month scenario framework assigns 55% to a base case of $105-$118, in which the turnaround grinds forward without a clean inflection, EPS moves toward the $5.50 consensus, the 28.6x forward PE holds, and the stock trades near the $111.07 average target with the $111.50 52-week high as resistance. The 25% bull case targets $125-$141, requiring positive comparable sales in both North America and International, operating margin crossing 12%, analyst upgrades above $120, and a breakout above $111.50. The 20% bear case targets $82-$93, essentially the $81.97 52-week low, if International weakness persists and margin recovery fails. The base case is most likely because it requires only modest progress rather than a dramatic inflection, and its key assumption is that revenue returns to growth consistent with the $48.65 billion consensus while margins improve gradually but stay below the fiscal 2023-2024 peak.

The stock is fairly valued to modestly expensive. The trailing PE of 43.1x looks rich for a business with a 6.66% net margin and negative revenue growth, but it compresses to 28.6x forward — a 34% gap that shows the market is already paying for an earnings recovery toward the $5.50 consensus EPS. On EV/EBITDA of 21.8x and EV/Sales of 3.69x, Starbucks trades at a clear premium to restaurant peers, a premium defensible only if operating margins return toward the 14%+ levels of fiscal 2023-2024 from today's 9.74%. The 2.87x PS ratio is not at a historical extreme, and the PEG of 1.21 suggests the growth embedded in the forward multiple is not egregiously priced if recovery delivers. What the valuation implies is that the market expects the turnaround to work — it leaves little margin of safety, which is why the consensus target offers only 4.3% upside and the analyst range spans a wide $82 to $141.

From a risk/reward standpoint the setup is balanced rather than compelling: at $106.44 the 30-analyst average target of $111.07 implies only +4.3% upside, while the bear-case path to the $82 low target represents roughly 23% downside. The quality is real — a 67.7% gross margin, a 41,000-store global footprint, and a PEG of 1.21 if the EPS recovery toward $5.50 materializes — and the stock has outperformed SPY by 16.40 points over the past month on turnaround optimism. But the recommendation mean of 2.33 (15 Buy, 18 Hold, 3 Sell) and five Neutral reiterations in late October and early November show analysts are waiting for proof, not buying the narrative. It is a reasonable buy for long-term investors seeking quality-brand exposure who can tolerate a 1.012 beta and a dividend currently uncovered at a 1.12 payout ratio, particularly on a pullback toward $93-$95; it is a poor buy for anyone chasing the 14.14% one-month rally at a 43.1x trailing multiple with revenue still declining 4.47%.

Starbucks is better suited to a long-term holding period of at least 12-24 months than to short-term trading. The turnaround is a multi-quarter margin story — operating margin must travel from 9.74% toward 14%+, and quarterly EPS has been erratic ($0.26, $0.45, $0.91, $0.59) rather than trending cleanly — so earnings visibility is limited over a single quarter. The 1.012 beta means the stock offers no defensive offset in a market selloff, and the 4.62 short ratio plus a 36% spread between the $81.97 low and $111.50 high create meaningful near-term volatility for traders. Income seekers should note the 2.59% yield is not currently covered by earnings at a 1.12 payout ratio, making the dividend a risk rather than a support. A concrete minimum holding period of 18-24 months allows time for two to three earnings cycles to confirm whether comparable sales and margins are genuinely inflecting, and accumulating on weakness toward the $93-$95 support zone would improve the entry for that horizon.